Health

  • Bio
    Mendel.ai nabs $2 million to match cancer patients with the latest clinical trials

    Mendel.ai nabs $2 million to match cancer patients with the latest clinical trials

    Dr. Karim Galil was tired of losing patients to cancer. He was tired of messy medical records. And he was tired of trying to stay on top of all the clinical trials touting one solution or another. Losing patience and patients, Galil decided to create an organized and artificially intelligent system to match those under his care with the best diagnostic and treatment methods available. Read More

  • Bio

    9 promising at-home lab test startups for everything from fertility to STDs

    It’s easier than ever to skip the doctor and go straight for the at-home test these days, thanks to updated regulations and the technology to match — and for many, it’s the answer to invasive and expensive hospital visits. A new army of startups has popped up in the last couple of years to offer you low-cost options for everything from breast cancer inheritance to HIV. Read More

  • GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market

    GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market

    While $5.7 billion was invested in companies developing cellular and genetic therapies, and with 800 clinical trials initiated worldwide and the first two CAR-T cell therapies expected to launch into market later this year, businesses still say the ability to get these treatments to patients is limited by paperwork, supply chain management, and last mile delivery. Read More

  • Withings is now Nokia

    Withings is now Nokia

    Nokia announced at Mobile World Congress back in February that it would be sunsetting the Withings brand this summer. After giving fans of the French connected health device maker sufficient time to mourn, the brand name is finally officially being removed from its existing product lines. All Withings products will be branded Nokia from here on out.  The transition will be marked by a few… Read More

  • Birth control app Nurx now delivers to the ‘contraceptive deserts’ of Texas

    Birth control app Nurx now delivers to the ‘contraceptive deserts’ of Texas

    About half the counties in Texas don’t have the number of public clinics required to meet the contraceptive needs of the population. So Nurx, an at-home birth control delivery app, decided to give women in the state the option to get birth control whenever they want and without ever needing to step into a clinic or even physically see a doctor. Read More

  • Bio
    Mary Meeker’s latest trends report highlights Silicon Valley’s role in the future of healthcare

    Mary Meeker’s latest trends report highlights Silicon Valley’s role in the future of healthcare

    Mary Meeker’s latest Internet Trends Report, out today, was full of insights on how tech is shaping our future — including now in healthcare. This was the first year Meeker included healthcare in her report and it shows just how much of a role tech is going to play in improving our lives going forward. Here are a few key insights from the report. Read More

  • Cera is building an AI for social care decision support

    Cera is building an AI for social care decision support

    Can AI overhaul the social care system? That’s the pitch underpinning UK home care provider Cera’s plans. The startup has today taken the tiniest baby steps to launch an AI chatbot that it hopes will, at an unspecified point in future, be able to assist carers with recommendations for home care of people with conditions such as dementia. Read More

  • Oscar Health only lost half as much money as it did last year

    Oscar Health only lost half as much money as it did last year

    Oscar Health CEO Mario Schlosser came on stage with me at Disrupt yesterday at our annual New York conference to talk about his company and the more than $200 million it took in net losses last year. Though he mentioned the Feds still owed his company the equivalent amount in Obamacare subsidies it still wasn’t a good look for a startup struggling among bigger insurance firms with… Read More